Anton Parker

1.5k total citations
24 papers, 673 citations indexed

About

Anton Parker is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Anton Parker has authored 24 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 12 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Anton Parker's work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Anton Parker is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Anton Parker collaborates with scholars based in United Kingdom, Spain and Germany. Anton Parker's co-authors include David Oscier, Zadie Davis, Matthew Rose‐Zerilli, Jonathan C. Strefford, Helen Parker, Andrew Collins, Jenny Orchard, Anne Gardiner, Daniel Catovsky and Jade Forster and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Anton Parker

24 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Parker United Kingdom 12 433 309 281 236 91 24 673
Rogier Kersseboom Netherlands 13 281 0.6× 152 0.5× 205 0.7× 280 1.2× 113 1.2× 21 657
Zoltán Mátrai Hungary 10 429 1.0× 289 0.9× 140 0.5× 214 0.9× 75 0.8× 30 561
Michael J. Eckart Germany 7 648 1.5× 507 1.6× 195 0.7× 397 1.7× 181 2.0× 13 928
Amber C. Donahue United States 14 122 0.3× 86 0.3× 286 1.0× 215 0.9× 92 1.0× 22 583
Rebecca Auer United Kingdom 14 445 1.0× 469 1.5× 143 0.5× 100 0.4× 98 1.1× 36 647
Sandrine Geffroy France 14 419 1.0× 176 0.6× 393 1.4× 114 0.5× 578 6.4× 32 949
Elisabeth Bertrand France 9 347 0.8× 309 1.0× 216 0.8× 294 1.2× 110 1.2× 18 645
Amy Billet United States 7 169 0.4× 64 0.2× 127 0.5× 213 0.9× 117 1.3× 8 580
Mylène Gadoux France 11 135 0.3× 195 0.6× 429 1.5× 52 0.2× 59 0.6× 15 679
Botond Tímár Hungary 11 156 0.4× 176 0.6× 112 0.4× 77 0.3× 68 0.7× 34 355

Countries citing papers authored by Anton Parker

Since Specialization
Citations

This map shows the geographic impact of Anton Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Parker more than expected).

Fields of papers citing papers by Anton Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Parker. The network helps show where Anton Parker may publish in the future.

Co-authorship network of co-authors of Anton Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Parker. A scholar is included among the top collaborators of Anton Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Parker. Anton Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mactier, Helen, et al.. (2017). Increased DNA Methylation of ABCB1 , CYP2D6 , and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. The Journal of Pediatrics. 190. 180–184.e1. 35 indexed citations
2.
Davis, Zadie, Francesco Forconi, Anton Parker, et al.. (2016). The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity. British Journal of Haematology. 173(1). 127–136. 15 indexed citations
3.
Palma, Marzia, Anton Parker, Mohammad Hojjat‐Farsangi, et al.. (2013). Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia. Experimental Hematology. 41(7). 615–626. 13 indexed citations
4.
Skowrońska, Anna, Anton Parker, Ceri Oldreive, et al.. (2012). Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial. Journal of Clinical Oncology. 30(36). 4524–4532. 77 indexed citations
5.
Oscier, David, Matthew Rose‐Zerilli, Nils Winkelmann, et al.. (2012). The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood. 121(3). 468–475. 150 indexed citations
6.
Rose‐Zerilli, Matthew, Jade Forster, Helen Parker, et al.. (2012). The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL. Blood. 120(21). 658–658. 2 indexed citations
7.
Irving, Laura, Tryfonia Mainou‐Fowler, Anton Parker, et al.. (2011). Methylation markers identify high risk patients inIGHVmutated chronic lymphocytic leukemia. Epigenetics. 6(3). 300–306. 17 indexed citations
8.
Amin, Shilu, Meagan J. Walsh, Caroline Wilson, et al.. (2011). Cross‐talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL. Journal of Cellular and Molecular Medicine. 16(9). 2074–2084. 10 indexed citations
9.
Parker, Anton, et al.. (2011). Telomere Length Is An Independent Predictor of Outcome After Therapy in CLL: Results From the UKCLL4 Trial,. Blood. 118(21). 3884–3884. 1 indexed citations
10.
Ross, Jeffrey S., Doron Lipson, Roman Yelensky, et al.. (2011). Comprehensive next-generation sequencing for clinically actionable mutations from formalin-fixed cancer tissues.. Journal of Clinical Oncology. 29(15_suppl). 10564–10564. 5 indexed citations
11.
Rose‐Zerilli, Matthew, David González, Helen Parker, et al.. (2011). 4.18 The Clinical Significant of NOTCH1 and MYD88 Mutations in Patients Enrolled onto the UK CLL4 Treatment Trial and in an Early Stage A CLL Cohort. Clinical Lymphoma Myeloma & Leukemia. 11. S229–S229. 1 indexed citations
12.
Parker, Helen, Matthew Rose‐Zerilli, Anton Parker, et al.. (2010). 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia. 25(3). 489–497. 75 indexed citations
13.
Strefford, Jonathan C., Helen Parker, Anton Parker, et al.. (2009). 13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.. Blood. 114(22). 671–671. 3 indexed citations
14.
Parker, Anton, Shilu Amin, Helen White, et al.. (2008). Epigenetic Regulation of ZAP70 in Chronic Lymphocytic Leukemia.. Blood. 112(11). 2246–2246. 1 indexed citations
15.
Strathdee, Gordon, Tessa L. Holyoake, Anton Parker, et al.. (2007). Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis. Clinical Cancer Research. 13(17). 5048–5055. 103 indexed citations
16.
Amin, Shilu, Anton Parker, & Jelena Mann. (2007). ZAP70 in chronic lymphocytic leukaemia. The International Journal of Biochemistry & Cell Biology. 40(9). 1654–1658. 9 indexed citations
17.
Best, Giles, Rachel Ibbotson, Anton Parker, et al.. (2006). ZAP‐70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry Part B Clinical Cytometry. 70B(4). 235–241. 27 indexed citations
18.
Ibbotson, Rachel, Anton Parker, & David Oscier. (2005). Splenic Marginal Zone Lymphoma: 7q Abnormalities. PubMed. 115. 241–250. 2 indexed citations
19.
Corcoran, Martin, Anton Parker, Jenny Orchard, et al.. (2005). ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia.. PubMed. 90(8). 1078–88. 66 indexed citations
20.
Orchard, Jenny, Giles Best, Rachel Ibbotson, Anton Parker, & David Oscier. (2005). ZAP-70 by Flow Cytometry: Comparison of Methodologies, and with IgVH Mutational and ZAP-70 Methylation Status.. Blood. 106(11). 1181–1181. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rogier Kersseboom Breakdown of academic impact, for papers by Zoltán Mátrai Breakdown of academic impact, for papers by Michael J. Eckart Breakdown of academic impact, for papers by Amber C. Donahue Breakdown of academic impact, for papers by Rebecca Auer Breakdown of academic impact, for papers by Sandrine Geffroy Breakdown of academic impact, for papers by Elisabeth Bertrand Breakdown of academic impact, for papers by Amy Billet Breakdown of academic impact, for papers by Mylène Gadoux Breakdown of academic impact, for papers by Botond Tímár
Rankless by CCL
2026